Orthopedic company Enovis has made a binding offer to acquire surgical robotics developer eCential Robotics for an enterprise value of €155 million, plus up to €35 million in milestone payments. The deal, expected to close by the end of 2026, aims to expand Enovis' ASTRA ecosystem into robotics, with plans to launch a next-generation platform for total knee procedures within two years and a shoulder application afterward. Initial commercial contributions are expected in 2028. Enovis expects the deal to temporarily dilute adjusted EBITDA margins by roughly 100 basis points in 2027 and increase leverage by about half a turn.